122 results on '"Stypmann, Jörg"'
Search Results
2. Prognostic implication of myocardial perfusion and contractile reserve in end-stage renal disease: A direct comparison of myocardial perfusion scintigraphy and dobutamine stress echocardiography
3. Regional Classification of Left Ventricular Wall in Small Animal Ultrasound Imaging
4. Histogram-Based Optical Flow for Functional Imaging in Echocardiography
5. Testicular blood supply is altered in the 41,XXY* Klinefelter syndrome mouse model
6. Molecular Changes of the Myocardium after Mechanical Circulatory Support
7. Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from 6 months after heart transplantation: The randomized MANDELA study
8. Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
9. Mechanosensing by β1 integrin induces angiocrine signals for liver growth and survival
10. Transthyretin-assoziierte familiäre Amyloidpolyneuropathie
11. New insights in efficacy of different dosages of enzyme replacement therapy due to treatment switch in Fabry disease
12. Microstructural cerebral lesions are associated with the severity of central sleep apnea with Cheyne-Stokes-respiration in heart failure and are modified by PAP-therapy
13. Fabry disease under enzyme replacement therapy—new insights in efficacy of different dosages
14. FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
15. De novo hereditary (familial) amyloid polyneuropathy (FAP) in a FAP liver recipient
16. Treatment and clinical survey of females with Fabry disease in Germany
17. Renal function at ERT-naïve baseline predicts long-term outcome in Fabry disease
18. Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound
19. Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry disease
20. Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
21. Sphingosine‐1‐Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca 2+ Sensitivity and Na + /H + Exchange and Mediates Protection by Ischemic Preconditioning
22. Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
23. SP171THE SYNTHETIC TIE2 AGONIST VASCULOTIDE PROTECTS RENAL VASCULAR BARRIER FUNCTION IN ISCHEMIC ACUTE KIDNEY INJURY
24. Imaging Reveals the Connection Between Spontaneous Coronary Plaque Ruptures, Atherothrombosis, and Myocardial Infarctions in HypoE/SRBI−/− Mice
25. Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch–2-Year Follow-Up
26. The Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney Injury
27. Fabry patients after enzyme replacement therapy dose reduction and treatment switch: Renal impairment after 24months follow-up
28. Antibody-mediated inhibition of enzyme replacement therapy in Fabry disease results in impaired cardiac and renal function
29. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II
30. Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease
31. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
32. The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation
33. Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients
34. Inhomogeneous myocardial stress perfusion in SPECT studies predicts future allograft dysfunction in heart transplant recipients
35. Neutrophil gelatinase-associated lipocalin (NGAL) in heart transplant recipients after conversion to everolimus therapy
36. Author's reply
37. Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue Factor
38. Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study
39. Dronedarone and digitalis: individually reduced post-repolarization refractoriness enhances life-threatening arrhythmias
40. Velocity mapping of the aortic flow at 9.4 T in healthy mice and mice with induced heart failure using time-resolved three-dimensional phase-contrast MRI (4D PC MRI)
41. Automatic classification of left ventricular wall segments in small animal ultrasound imaging
42. Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction Versus Treatment Switch
43. Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling
44. Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF–NGR using multi-modal imaging
45. Survival Results After Implantation of Intrapericardial Third-Generation Centrifugal Assist Device: An INTERMACS-Matched Comparison Analysis
46. Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients
47. Rapamycin extends murine lifespan but has limited effects on aging
48. Cardiac-respiratory self-gated cine ultra-short echo time (UTE) cardiovascular magnetic resonance for assessment of functional cardiac parameters at high magnetic fields
49. Brainstem Involvement as a Cause of Central Sleep Apnea: Pattern of Microstructural Cerebral Damage in Patients with Cerebral Microangiopathy
50. Anticancer Therapy by Tumor Vessel Infarction with Polyethylene Glycol Conjugated Retargeted Tissue Factor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.